journal article·2023-06

Celastrol-encapsulated microspheres prepared by microfluidic electrospray for alleviating inflammatory pain

Huiyu Zheng, Cheng Zhao, Yitian Lu, Jun Cao, Fanning Zeng, Huan Wang, Zaisheng Qin, Tao Tao

Publisher page

Abstract

Inflammatory pain is induced by trauma, infection, chemical stimulation, etc. It causes severe physical and psychological agony to patients. Celastrol has powerful anti-inflammatory property and has achieved good results in various inflammation-related diseases. However, the low water solubility and multi-system toxicity limit its clinical application. Herein, we proposed alginate microspheres with core-shell structure which encapsulated celastrol by microfluidic electrospray to effectively overcome the shortcomings and improve the therapeutic effect. The microspheres had uniform size and good biocompatibility, and could release the loaded drugs in the gut. The behavioral tests showed that the celastrol-loaded microspheres effectively alleviated inflammatory pain, and the hematoxylin and eosin staining (HE staining), immunofluorescence and detection of inflammatory cytokines showed the anti-inflammatory effect. These results indicated that the microspheres could reduce dose and toxicity without affecting efficacy, and facilitate the application of celastrol in different clinical situations.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Natural Compounds in Disease Treatment · Nanoparticle-Based Drug Delivery · Phytochemistry and biological activity of medicinal plants

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (57)

Show source-provided references
1. Pain and immunity: implications for host defence10.1038/s41577-019-0147-2 ↗
2. Preclinical assessment of inflammatory pain10.1111/cns.12486 ↗
3. Pain and the immune system: emerging concepts of IgG-mediated autoimmune pain and immunotherapies10.1136/jnnp-2018-318556 ↗
4. Nonsteroidal anti-inflammatory drugs (NSAIDs) in older people: prescribing patterns according to pain prevalence and adherence to clinical guidelines10.1016/j.pain.2014.06.009 ↗
5. Capturing novel non-opioid pain targets10.1016/j.biopsych.2019.06.017 ↗
6. Celastrol: a spectrum of treatment opportunities in chronic diseases10.3389/fmed.2017.00069 ↗
7. Celastrol ameliorates inflammatory pain and modulates HMGB1/NF-κB signaling pathway in dorsal root ganglion10.1016/j.neulet.2018.11.002 ↗
8. Celastrol ameliorates osteoarthritis via regulating TLR2/NF-κB signaling pathway
9. Inflammation-targeted celastrol nanodrug attenuates collagen-induced arthritis through NF-κB and Notch1 pathways10.1021/acs.nanolett.0c03279 ↗
10. Celastrol: a review of useful strategies overcoming its limitation in anticancer application10.3389/fphar.2020.558741 ↗
11. Celastrol: progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology10.1016/j.ejmech.2020.112081 ↗
12. Oriented boronate affinity–imprinted inverse opal hydrogel for glycoprotein assay via colorimetry10.1007/s00604-020-04320-9 ↗
13. Boronate affinity molecularly imprinted inverse opal particles for multiple label-free bioassays10.1039/C5CC09371F ↗
14. Responsive Janus structural color hydrogel micromotors for label-free multiplex assays10.34133/2021/9829068 ↗
15. Biomimetic epithelium/endothelium on chips
16. Tubular inverse opal scaffolds for biomimetic vessels10.1039/C6NR03173K ↗
17. Living materials for regenerative medicine
18. Enzyme-functionalized structural color hydrogel particles for urea detection and elimination10.1016/j.jclepro.2021.128149 ↗
19. Emerging droplet microfluidics10.1021/acs.chemrev.6b00848 ↗
20. Artificial spider silk based programmable woven textile for efficient wound management10.1002/adfm.202107707 ↗
21. Multiplex assays of bladder cancer protein markers with magnetic structural color hydrogel microcarriers based on microfluidics10.1016/j.snb.2021.130464 ↗
22. Shear-flow-induced graphene coating microfibers from microfluidic spinning
23. Emerging technologies in multi-material bioprinting10.1002/adma.202104730 ↗
24. Enzymatic inverse opal hydrogel particles for biocatalyst10.1021/acsami.7b01866 ↗
25. Polymer-based responsive structural color materials10.1016/j.pmatsci.2023.101091 ↗
26. Ice-inspired lubricated drug delivery particles from microfluidic electrospray for osteoarthritis treatment10.1021/acsnano.1c09325 ↗
27. Microfluidic electrospray photo-crosslinkable κ-carrageenan microparticles for wound healing
28. Microfluidic electrospray niacin metal-organic frameworks encapsulated microcapsules for wound healing10.34133/2019/6175398 ↗
29. Enhancement of oral bioavailability of tripterine through lipid nanospheres: preparation, characterization, and absorption evaluation10.1002/jps.23967 ↗
30. Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble drugs10.1248/bpb.29.508 ↗
31. Roe-inspired stem cell microcapsules for inflammatory bowel disease treatment10.1073/pnas.2112704118 ↗
32. Prospects of brown seaweed polysaccharides (BSP) as prebiotics and potential immunomodulators10.1111/jfbc.12392 ↗
33. Injectable hydrogels for spinal cord injury repair
34. Pollen-inspired microparticles with strong adhesion for drug delivery10.1016/j.apmt.2018.09.016 ↗
35. Biomimetic enzyme cascade reaction system in microfluidic electrospray microcapsules10.1126/sciadv.aat2816 ↗
36. Cheerios effect inspired microbubbles as suspended and adhered oral delivery systems10.1002/advs.202004184 ↗
37. Biomass microcapsules with stem cell encapsulation for bone repair10.1007/s40820-021-00747-8 ↗
38. Bio-inspired intestinal scavenger from microfluidic electrospray for detoxifying lipopolysaccharide
39. Celastrol-loaded galactosylated liposomes effectively inhibit AKT/c-met-triggered rapid hepatocarcinogenesis in mice10.1021/acs.molpharmaceut.9b00428 ↗
40. PEGylated polyaminoacid-capped mesoporous silica nanoparticles for mitochondria-targeted delivery of celastrol in solid tumors10.1016/j.colsurfb.2018.02.015 ↗
41. Rapid ultratough topological tissue adhesives
42. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate–chitosan beads10.1016/j.ijpharm.2006.05.054 ↗
43. Anisotropic structural color particles from colloidal phase separation
44. Scaffolds with anisotropic structure for neural tissue engineering
45. Natural proteins-derived asymmetric porous conduit for peripheral nerve regeneration
46. Celastrol ameliorates Propionibacterium acnes/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP310.1016/j.phymed.2020.153398 ↗
47. Targeted delivery of celastrol to glomerular endothelium and podocytes for chronic kidney disease treatment10.1007/s12274-021-3894-x ↗
48. Strong inhibition of celastrol towards UDP-glucuronosyl transferase (UGT) 1A6 and 2B7 indicating potential risk of UGT-based herb-drug interaction10.3390/molecules17066832 ↗
49. Responsive inverse opal scaffolds with biomimetic enrichment capability for cell culture10.34133/2019/9783793 ↗
50. CYP450s-activity relations of celastrol to interact with triptolide reveal the reasons of hepatotoxicity of Tripterygium wilfordii10.3390/molecules24112162 ↗
51. Celastrol attenuates inflammatory and neuropathic pain mediated by cannabinoid receptor type 210.3390/ijms150813637 ↗
52. Celastrol efficacy by oral administration in the adjuvant-induced arthritis model10.3389/fmed.2020.00455 ↗
53. Celastrol attenuates pain and cartilage damage via SDF-1/CXCR4 signalling pathway in osteoarthritis rats10.1111/jphp.12835 ↗
54. Celastrol attenuates incision-induced inflammation and pain associated with inhibition of the NF-κB signalling pathway via SARM10.1016/j.lfs.2018.05.020 ↗
55. Celastrol treatment protects against acute ischemic stroke-induced brain injury by promoting an IL-33/ST2 axis-mediated microglia/macrophage M2 polarization10.1186/s12974-018-1124-6 ↗
56. Functional hydrogels as wound dressing to enhance wound healing10.1021/acsnano.1c04206 ↗
57. Fast green FCF alleviates pain hypersensitivity and down-regulates the levels of spinal P2X4 expression and pro-inflammatory cytokines in a rodent inflammatory pain model10.3389/fphar.2018.00534 ↗